Elias A. T. Koch

机构：Comprehensive Cancer Center Erlangen · ORCID：0000-0003-2005-7533

发表论文 30 篇 · 总被引 401 次 · h-index 12

代表论文

Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023 · Cancer Treatment Reviews · 被引 32)
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis (2021 · Cancers · 被引 32)
A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022 · Frontiers in Immunology · 被引 31)
Clinical determinants of long-term survival in metastatic uveal melanoma (2021 · Cancer Immunology Immunotherapy · 被引 21)
The Current State of Systemic Therapy of Metastatic Uveal Melanoma (2024 · American Journal of Clinical Dermatology · 被引 17)
Safety of topical interventions for the treatment of actinic keratosis (2021 · Expert Opinion on Drug Safety · 被引 15)